Custom antibody market projected to reach $1.13 billion by 2031
A market report by research firm MarketsandMarkets estimates the custom antibody sector will grow at a compound annual growth rate of 9.5% over the next five years.
The global market for custom antibodies is forecast to grow to $1.13 billion by 2031, rising from a 2026 valuation of $0.72 billion. According to data published by MarketsandMarkets, the sector is expected to maintain a compound annual growth rate (CAGR) of 9.5% throughout the forecast period.
This market segment encompasses the development and production of specialized antibodies used primarily in drug discovery, disease diagnostics, and clinical research. The projected growth reflects sustained demand for precision biological tools within the life sciences industry.
As the industry matures, stakeholders are increasingly focused on improving yield and specificity in antibody engineering. The report suggests that continued R&D investment and the expansion of biotechnology infrastructures will be the primary drivers of this market valuation through the end of the decade.